Cargando…

Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling

Detalles Bibliográficos
Autores principales: Montanha, Maiara Camotti, Fabrega, Francesc, Howarth, Alice, Cottura, Nicolas, Kinvig, Hannah, Bunglawala, Fazila, Lloyd, Andrew, Denti, Paolo, Waitt, Catriona, Siccardi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652258/
https://www.ncbi.nlm.nih.gov/pubmed/36112343
http://dx.doi.org/10.1007/s40262-022-01178-3
_version_ 1784828429184532480
author Montanha, Maiara Camotti
Fabrega, Francesc
Howarth, Alice
Cottura, Nicolas
Kinvig, Hannah
Bunglawala, Fazila
Lloyd, Andrew
Denti, Paolo
Waitt, Catriona
Siccardi, Marco
author_facet Montanha, Maiara Camotti
Fabrega, Francesc
Howarth, Alice
Cottura, Nicolas
Kinvig, Hannah
Bunglawala, Fazila
Lloyd, Andrew
Denti, Paolo
Waitt, Catriona
Siccardi, Marco
author_sort Montanha, Maiara Camotti
collection PubMed
description
format Online
Article
Text
id pubmed-9652258
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-96522582022-11-15 Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling Montanha, Maiara Camotti Fabrega, Francesc Howarth, Alice Cottura, Nicolas Kinvig, Hannah Bunglawala, Fazila Lloyd, Andrew Denti, Paolo Waitt, Catriona Siccardi, Marco Clin Pharmacokinet Correction Springer International Publishing 2022-09-16 2022 /pmc/articles/PMC9652258/ /pubmed/36112343 http://dx.doi.org/10.1007/s40262-022-01178-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Montanha, Maiara Camotti
Fabrega, Francesc
Howarth, Alice
Cottura, Nicolas
Kinvig, Hannah
Bunglawala, Fazila
Lloyd, Andrew
Denti, Paolo
Waitt, Catriona
Siccardi, Marco
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
title Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
title_full Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
title_fullStr Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
title_full_unstemmed Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
title_short Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
title_sort correction to: predicting drug–drug interactions between rifampicin and ritonavir-boosted atazanavir using pbpk modelling
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652258/
https://www.ncbi.nlm.nih.gov/pubmed/36112343
http://dx.doi.org/10.1007/s40262-022-01178-3
work_keys_str_mv AT montanhamaiaracamotti correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT fabregafrancesc correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT howarthalice correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT cotturanicolas correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT kinvighannah correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT bunglawalafazila correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT lloydandrew correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT dentipaolo correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT waittcatriona correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling
AT siccardimarco correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling